e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Immune responses for the diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Frequent detection of discordant results of two interferon-γ release assays in an aged population
F. C. Ringshausen, H. Knoop, A. Nienhaus, J. Bünger, V. Harth, F. Hoffmeyer, R. Merget, G. Schultze-Werninghaus, G. Rohde (Bochum, Hamburg, Germany; , Switzerland; , Netherlands)
Source:
Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Session:
Immune responses for the diagnosis of tuberculosis
Session type:
E-Communication Session
Number:
274
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. C. Ringshausen, H. Knoop, A. Nienhaus, J. Bünger, V. Harth, F. Hoffmeyer, R. Merget, G. Schultze-Werninghaus, G. Rohde (Bochum, Hamburg, Germany; , Switzerland; , Netherlands). Frequent detection of discordant results of two interferon-γ release assays in an aged population. Eur Respir J 2010; 36: Suppl. 54, 274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Sequential analysis of interferon-γ release assay results in active tuberculosis patients
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Performance of IFN-γ release assays for tuberculosis detection in immune-compromised children in a low prevalence country
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Frequency of discordant results in interferon-γ release assay serial testing for latent tuberculosis infection in health care workers
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Serial testing with the interferon-γ release assay in Portuguese healthcare workers
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-γ release assays
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Concordance between tuberculin skin test and interferon-gamma release assay in
Mycobacterium tuberculosis
infected children aged up to five years
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Serial testing with the interferon-γ release assay in German healthcare workers
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Serial interferon-gamma release assay in children younger than 5 years with latent tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019
Comparison of susceptibility testing results of MAC isolated from HIV-positive andHIV-negative patients
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Specificity of mycobacterial population susceptibility to TB drugs in patients aged 13-17
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002
Dynamics of asthma prevalence in children in the Novosibirsk (preliminary results)
Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Year: 2012
False-negative interferon gamma release assay results in active tuberculosis: a TBNET study
Source: Eur Respir J 2015; 45: 279-283
Year: 2015
Conversion and reversion rates in serial examination in German healthcare worker with the interferon-gamma release assay
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Early detection of COPD: evidence from a population cohort study
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Does response bias of the mother alter the results in a children cohort study? An illustration
Source: Eur Respir J 2003; 22: Suppl. 45, 506s
Year: 2003
Targeted sequencing of 130 asthma candidate genes and association testing of rare variants with age of onset in Norwegian asthma patients.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients
Source: Eur Respir J 2010; 35: 1179-1182
Year: 2010
Early BCG-vaccination may result in suppression of
in-vitro
TH2-cytokine response at the age of 4 and 18 months in high-risk newborns from non-allergic mothers
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept